# Treatment for Subjects With Active Rheumatoid Arthritis (RA)

> **NCT00110903** · PHASE3 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept Liquid

## Key facts

- **NCT ID:** NCT00110903
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110903, "Treatment for Subjects With Active Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00110903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*